Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ibuprofen + aspirin-Assiut University refers to a combination of two standard non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen and aspirin, utilized in a clinical trial (NCT03456531) sponsored by Assiut University. The trial evaluated the efficacy of pulsed radiofrequency to the suprascapular nerve compared to this NSAID combination for the treatment of chronic pain and restricted range of motion in patients with frozen shoulder (adhesive capsulitis). Ibuprofen and aspirin both act by inhibiting the cyclooxygenase enzymes COX-1 and COX-2, which are responsible for the biosynthesis of prostaglandins. While ibuprofen provides reversible inhibition, aspirin provides irreversible inhibition and is also commonly used for its antiplatelet properties. In this clinical context, the combination serves as a conventional pharmacological control against an interventional nerve stimulation technique.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + aspirin.